| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| MCCRANIE J DANIEL | Director | C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT | /s/ Arthi Chakravarthy, Attorney-in-Fact for John Daniel McCranie | 26 Aug 2025 | 0001189710 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ENVX | Common Stock | Award | $0 | +25,700 | $0.000000 | 25,700 | 12 Aug 2025 | Direct | F1 | |
| transaction | ENVX | Common Stock | Award | $0 | +15,178 | +59% | $0.000000 | 40,878 | 12 Aug 2025 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | Reflects shares issuable upon the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in 12 equal quarterly installments measured from August 12, 2025, the vesting commencement date, subject to the Reporting Person's continuous service through each applicable vesting date. |
| F2 | Reflects shares issuable on the settlement of RSUs granted to the Reporting Person. 25% of the RSUs will vest on each of November 12, 2025, February 12, 2026, May 12, 2026 and the earlier of (i) June 12, 2026; or (ii) the date of the Issuer's 2026 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or not standing for re-election), subject to the Reporting Person's continuous service through each applicable vesting date. |
| F3 | Includes 40,878 shares issuable upon the settlement of RSUs granted to the Reporting Person. |